Sustainable synthesis and automated deposition: An accessible discovery screening library of fragment-like purines

Molecular Diversity

Volumn 16, Issue 3, 2012, Pages 541-551

  Kamper, Christoph ^a   Korpis, Katharina ^a   Specker, Edgar ^b   Anger, Lennart ^b   Neuenschwander, Martin ^b   Bednarski, Patrick J ^a   Link, Andreas ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

Cytotoxic activity; High throughput screening; Library synthesis; Modified purines

Indexed keywords

BENZYLAMINE DERIVATIVE; PURINE DERIVATIVE;

ARTICLE; BIOASSAY; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENTHALPY; ENTROPY; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; MOLECULAR LIBRARY; PRIORITY JOURNAL; PROTEIN MODIFICATION; PURINE SYNTHESIS; SCREENING;

EID: 84869507375     PISSN: 13811991     EISSN: 1573501X     Source Type: Journal    
DOI: 10.1007/s11030-012-9386-x     Document Type: Article

References (15)

1. Conejo-Garcia A, Cruz-Lopez O, Gomez-Perez V, Morales F, Garcia-Rubino ME, Kimatrai M, Nunez MC, M. Campos J (2010) Synthesis of purine derivatives as scaffolds for a diversity of biological activities. Curr Org Chem 14:2463-2482. doi:10.2174/138527210793358240
2. FoloppeN (2011) The benefits of constructing leads from fragment hits. Future Med Chem 3:1111-1115. doi:10.4155/fmc.11.46
3. Huang L, Cherng Y-C, Cheng Y-R, Jang J-P, Chao Y-L, Cherng Y-J (2007) An efficient synthesis of substituted cytosines and purines under focused microwave irradiation. Tetrahedron 63:5323-5327. doi:10.1016/j.tet.2007.02.124 (Pubitemid 46702213)
4. Legraverend M (2008) Recent advances in the synthesis of purine derivatives and their precursors. Tetrahedron 64:8585-8603. doi:10.1016/j.tet. 2008.05.115
5. Pathak AK, Pathak V, Seitz LE, Suling WJ, Reynolds RC (2004) Antimycobacterial agents. 1. Thio analogues of Purine. J Med Chem 47:273-276. doi:10.1021/jm030389b (Pubitemid 38040510)
6. Laufer SA, Dormeyer DM, Scior TR, Albrecht W, Hauser DRJ (2005) Synthesis and biological testing of purine derivates as potential ATP-competive kinase inhibitors. J Med Chem 48:710- 722. doi:10.1021/jm0408767 (Pubitemid 40209093)
7. Bracht K, Boubakari F, Grünert R, Bednarski PJ (2006) Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute data. Anticancer Drugs 17:41-51. doi:10.1097/01.cad. 0000190280.60005.05
8. Baum B, Muley L, Smolinski M, Heine A, Hangauer D, Klebe G (2010) Non-additivity of functional group contributions in protein- ligand binding: a comprehensive study by crystallography and isothermal titration calorimetry. J Mol Biol 397:1042-1054. doi:10.1016/j.jmb.2010.02.007
9. Freire E (2008) Do enthalpy and entropy distinguish first in class from best in class?. Drug Discov Today 13:869-874. doi:10.1016/j.drudis.2008.07.005
10. Freire E (2009) A thermodynamic approach to the affinity optimization of drug candidates. Chem Biol Drug Des 74:468-472. doi:10.1111/j.1747-0285.2009. 00880
11. Ferenczy GG, Keseru GM (2010) Enthalpic efficiency of ligand binding. J Chem Inf Model 50:1536-1541. doi:10.1021/ci100125a
12. Reynolds CH, Holloway MK (2011) Thermodynamics of Ligand binding and efficiency. ACS Med Chem Lett 2:433-437. doi:10.1021/ml200010k
13. Hauser DRJ, Scior TR, Dormeyer DM, Kammerer B, Laufer SA (2007) Synthesis, biological testing and binding mode prediction of 6,9-diarylpurin-8-ones as p38 MAP kinase inhibitor. J Med Chem 50:2060-2066. doi:10.1021/jm061061w (Pubitemid 46683059)
14. Lambertucci C, Antonini I, Buccioni M, Dal Ben D, Kachare DD, Volpini R, Klotz KN, Cristalli G (2009) 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands. Bioorg Med Chem 17:2812-2822. doi:10.1016/j.bmc.2009.02.030
15. Montgomery JA, Temple C Jr (1957) Synthesis of potential anticancer agents. IX. 9-Ethyl-6-substituted-purines. J Am Chem Soc 79:5238-5242. doi:10.1021/ja01576a046